NEWS

Updates on the Breast Cancer Working Group

Updates on the GI and Neuroendocrine Tumors Working Group

Dr. Karl Balabanian's Visit to Armenia

Updates on the IMMONC0008 Trial On Non-Small Cell Lung Cancer

Dr. Karl Balabanian to Visit Armenia this October

Shushan Hovsepyan Appointed as Innovation and Development Director at the Immune Oncology Research Institute

IMMONC at the ASCO 2024 Annual Meeting

Update on the “Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone. Can This Modality Improve the Antiemetic Effect” trial

Astghik Voskanyan presented recent developments of the BPDCN International Registry at the 29th Congress of EHA

OncoDaily Leukemia Conference

OncoThon 2024

IMMONC Team at AOC 2024

CLINICAL TRIAL APPROVAL GRANTED

Amalya Sargsyan has been awarded the ASCO IDEA Award

CLINICAL TRIAL UPDATE

IMMONC annual report for 2023